Prediction of Non-Relapse Mortality with Dynamic Easix Scores after Allogeneic Hematopoietic Cell Transplantation

被引:0
|
作者
Nawas, Mariam T. [1 ]
Sanchez-Escamilla, Miriam [2 ]
Devlin, Sean M. [3 ]
Maloy, Molly A. [4 ]
Perales, Miguel [4 ,5 ]
Giralt, Sergio A. [4 ,5 ]
Scordo, Michael [4 ,5 ]
机构
[1] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[2] Res Inst Marques Valdecilla IDIVAL, Dept Hematol Malignancies & Stem Cell Transplanta, Santander, Spain
[3] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, 1275 York Ave, New York, NY 10021 USA
[4] Mem Sloan Kettering Canc Ctr, Dept Med, Adult Bone Marrow Transplant Serv, 1275 York Ave, New York, NY 10021 USA
[5] Weill Cornell Med Coll, Dept Med, New York, NY USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
279
引用
收藏
页码:S189 / S190
页数:2
相关论文
共 50 条
  • [21] Development and Validation of a Concise Objectifiable Risk Evaluation Score for Non-Relapse Mortality after Allogeneic Hematopoietic Stem Cell Transplantation
    Weise, Gunnar
    Massoud, Radwan
    Krause, Rolf
    Heidenreich, Silke
    Janson, Dietlinde
    Klyuchnikov, Evgeny
    Wolschke, Christine
    Zeck, Gaby
    Kroeger, Nicolaus
    Ayuk, Francis
    CANCERS, 2024, 16 (03)
  • [22] Etiology and Spectrum of Non-Relapse Mortality after Reduced Intensity Allogeneic Hematopoietic Stem Cell Transplantation in Adults with Myeloid Neoplasms
    Eiten, Emily C.
    Hashmi, Shahrukh
    Litzow, Mark R.
    Hogan, William
    Gastineau, Dennis A.
    Patriaik, Mrinal
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (02) : S355 - S355
  • [23] EASIX and mortality after allogeneic stem cell transplantation
    Thomas Luft
    Axel Benner
    Tobias Terzer
    Sonata Jodele
    Christopher E. Dandoy
    Rainer Storb
    Lambros Kordelas
    Dietrich Beelen
    Ted Gooley
    Brenda M. Sandmaier
    Mohamed Sorror
    Markus Zeisbrich
    Aleksandar Radujkovic
    Peter Dreger
    Olaf Penack
    Bone Marrow Transplantation, 2020, 55 : 553 - 561
  • [24] EASIX and mortality after allogeneic stem cell transplantation
    Luft, Thomas
    Benner, Axel
    Terzer, Tobias
    Jodele, Sonata
    Dandoy, Christopher E.
    Storb, Rainer
    Kordelas, Lambros
    Beelen, Dietrich
    Gooley, Ted
    Sandmaier, Brenda M.
    Sorror, Mohamed
    Zeisbrich, Markus
    Radujkovic, Aleksandar
    Dreger, Peter
    Penack, Olaf
    BONE MARROW TRANSPLANTATION, 2020, 55 (03) : 553 - 561
  • [25] Citrulline Trajectory during Allogeneic Hematopoietic Stem Cell Transplantation Is Correlated to Conditioning Intensity and Non-Relapse Mortality
    Gomes, Christopher Nunes
    Seegers, Valerie
    Schmidt, Aline
    Orvain, Corentin
    Villate, Alban
    Bouvier, Anne
    Simard, Gille
    Del Galy, Aurelien Sutra
    Francois, Sylvie
    Giltat, Aurelien
    Robin, Jean Baptiste
    Delneste, Yves
    Ifrah, Norbert
    Hunault, Mathilde
    Thepot, Sylvain
    BLOOD, 2020, 136
  • [26] Treatment of myelodysplastic syndromes with allogeneic hematopoietic stem cell transplantation (HSCT)-impact of non-relapse mortality on outcomes
    Ativitavas, T
    Saliba, R
    Sergio, G
    Ghosh, S
    Champlin, R
    de Lima, M
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2006, 12 (02) : 28 - 29
  • [27] Recent decrease in non-relapse mortality due to GVHD and infection after allogeneic hematopoietic cell transplantation in non-remission acute leukemia
    Kurosawa, S.
    Yakushijin, K.
    Yamaguchi, T.
    Atsuta, Y.
    Nagamura-Inoue, T.
    Akiyama, H.
    Taniguchi, S.
    Miyamura, K.
    Takahashi, S.
    Eto, T.
    Ogawa, H.
    Kurokawa, M.
    Tanaka, J.
    Kawa, K.
    Kato, K.
    Suzuki, R.
    Morishima, Y.
    Sakamaki, H.
    Fukuda, T.
    BONE MARROW TRANSPLANTATION, 2013, 48 (09) : 1198 - 1204
  • [28] Recent decrease in non-relapse mortality due to GVHD and infection after allogeneic hematopoietic cell transplantation in non-remission acute leukemia
    S Kurosawa
    K Yakushijin
    T Yamaguchi
    Y Atsuta
    T Nagamura-Inoue
    H Akiyama
    S Taniguchi
    K Miyamura
    S Takahashi
    T Eto
    H Ogawa
    M Kurokawa
    J Tanaka
    K Kawa
    K Kato
    R Suzuki
    Y Morishima
    H Sakamaki
    T Fukuda
    Bone Marrow Transplantation, 2013, 48 : 1198 - 1204
  • [29] Pulmonary Arterial Hypertension (PAH) Is Associated with Increased Non-Relapse Mortality after Allogeneic Hematopoietic Cell Transplantation (allo HCT) for Myelofibrosis
    Gupta, Rohan
    Jamal, Faizi
    Yang, Dongyun
    Ali, Haris
    Aldoss, Ibrahim
    Al Malki, Monzr M.
    Mei, Matthew
    Salhotra, Amandeep
    Dobrin, Surime
    Tran, Michael
    Venkataraman, K.
    Palmer, Joycelynne
    Stein, Anthony S.
    Sandhu, Karamjeet S.
    Khaled, Samer K.
    Aribi, Ahmed
    Marcucci, Guido
    Forman, Stephen J.
    Snyder, David S.
    Nakamura, Ryotaro
    Pullarkat, Vinod
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
  • [30] Failure to Recover Thymopoiesis After Allogeneic Hematopoietic Stem Cell Transplantation Predicts for High Incidence of Opportunistic Infections and Non-Relapse Mortality
    Wils, Evert-Jan
    van der Holt, Bronno
    Broers, Annoek E. C.
    Posthumus-van Sluijs, Sandra J.
    Gratama, Jan W.
    Braakman, Eric
    Cornelissen, Jan J.
    BLOOD, 2010, 116 (21) : 362 - 363